The FBN1 gene provides instructions for making a large protein called fibrillin-1. This protein is transported out of cells into the extracellular matrix, which is an intricate lattice of proteins and other molecules that forms in the spaces between cells.
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.
If you have a new chronic illness or disability or if you have been dealing with health issues for some time now, it’s never too late to learn coping skills that might help you deal with this major challenge in your life.
CONNECT WITH US ON SOCIAL MEDIA
Medika.Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice.